logo

For the Inventor, By the Inventor

Ottendorf-Okrilla, Germany

Norbert Höfgen

This inventor holds 14 USPTO granted patents and 4 EPO patents. Top assignees: Elbion Ag, Janssen Pharmaceuticals, Inc., Biotie Therapies Corporation. Active years: 2006-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Norbert Höfgen. Retrieved from https://idiyas.com/inventor/norbert-höfgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 42.9

 

Average Co-Inventor Count = 7.2

ph-index = 5

Forward Citations = 77(Granted Patents)


Location History:

  • Ottendorf-Okrills, DE (2009)
  • Ottendorf-Okrilla, DE (2006 - 2023)

Company Filing History:

goldMedal5 out of 9 
 
Elbion Ag
 patents
silverMedal4 out of 161 
 
Janssen Pharmaceuticals, Inc.
 patents
bronzeMedal2 out of 28 
 
Biotie Therapies Corporation
 patents
4. 2 out of 3 
 
Elbion Gmbh
 patents
5. 1 out of 1,561 
 
Boehringer Ingelheim International Gmbh
 patents
6. 1 out of 1,309 
 
Wyeth
 patents
where one patent can have more than one assignee

Years Active: 2006-2023

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents
1. RE49517 - Pyrazoles (2023-05-01),
2. 10323021 - Triazoles as NR2B receptor inhibitors (2019-06-18),
3. 10155727 - Pyrazoles (2018-12-18),
4. 9981950 - Triazoles as NR2B receptor inhibitors (2018-05-29),
5. 9085584 - Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders (2015-07-21),
6. 7947705 - 7-azaindoles and the use thereof as therapeutic agents (2011-05-24),
7. 7875618 - Substituted imidazo[1,5-a]quinoxalines useful as inhibitors of phosphodiesterase 10 for the treatment of neurological and other disorders (2011-01-25),
8. 7683074 - 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them (2010-03-23),
9. 7550465 - Pyrido[3,2-e]pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them (2009-06-23),
10. 7419987 - 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them (2008-09-02),
11. 7169787 - 7-azaindoles, use thereof as phosphodiesterase 4 inhibitors and method for producing the same (2007-01-30),
12. 7166637 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4, and processes for preparing them (2007-01-23),
13. 7161009 - Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and processes for their preparation (2007-01-09),
14. 7122674 - Process for preparing high-purity hydroxyindolylglyoxylamides (2006-10-17),

Title: The Innovative Journey of Norbert Höfgen

Introduction: Norbert Höfgen, a pioneering inventor hailing from Ottendorf-Okrilla, Germany, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Norbert Höfgen's latest patents include a revolutionary solar-powered water purification system designed to provide clean drinking water in remote areas, and a smart home automation device that enhances energy efficiency.

Career Highlights: Throughout his illustrious career, Norbert Höfgen has been at the forefront of technological advancements. His inventions have not only improved the quality of life for many but have also garnered international recognition.

Collaborations: Norbert Höfgen has collaborated with leading research institutions and universities to further develop his inventions. His partnerships with top companies in the renewable energy sector have led to the successful implementation of his innovative ideas.

Conclusion: Norbert Höfgen's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His commitment to creating sustainable solutions for global challenges continues to inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…